Lv21
160 积分 2024-03-07 加入
EP.14B.02 Perioperative Efficacy and Safety of Efgartigimod in Thymoma Associated Myasthenia Gravis
2小时前
求助中
Factors associated with acute exacerbations of myasthenia gravis
7天前
已完结
Predictive score for oral corticosteroid-induced initial worsening of seropositive generalized myasthenia gravis
7天前
已完结
The Glucocorticoid Toxicity Index-Metabolic Domains, an abridged version of the Glucocorticoid Toxicity Index: post-hoc analysis of data from the ADVOCATE trial
29天前
已完结
Long-term outcome in patients with myasthenia gravis: one decade longitudinal study
29天前
已完结
TREATMENT OF MYASTHENIA GRAVIS WITH PREDNISONE
1个月前
已完结
Benefit from Alternate-Day Prednisone in Myasthenia Gravis
1个月前
已完结
Predictive score for oral corticosteroid-induced initial worsening of seropositive generalized myasthenia gravis
1个月前
已完结
How should newer therapeutic agents be incorporated into the treatment of patients with myasthenia gravis?
1个月前
已完结
Myasthenia gravis: the changing treatment landscape in the era of molecular therapies
1个月前
已完结
皖公网安备34019202002308
